Reaction
Eyelid Disorder reporting signals
As of the last recalculation, Eyelid Disorder appears in 2,272 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is BIMATOPROST (PRR 23.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bimatoprost | 72 | 23.6 | 23.7 |
| Desloratadine | 23 | 19.8 | 19.9 |
| Drs. Clotrimazole | 24 | 19.2 | 19.3 |
| Family Wellness Clotrimazole | 24 | 19.2 | 19.3 |
| Clotrimazole Topical | 24 | 19.2 | 19.2 |
| Lifitegrast | 32 | 18.2 | 18.2 |
| Clotrimazole | 24 | 18.1 | 18.1 |
| Brinzolamide | 17 | 18.1 | 18.1 |
| Ketoconazole | 33 | 17.7 | 17.7 |
| Timolol Maleate | 18 | 16.8 | 16.8 |
| Carboxymethylcellulose Sodium | 16 | 15.7 | 15.7 |
| Latanoprost | 80 | 15.1 | 15.1 |
| Travoprost | 14 | 14.9 | 14.9 |
| Dorzolamide Hydrochloride And Timolol Maleate | 11 | 12.8 | 12.8 |
| Brimonidine Tartrate | 21 | 10.9 | 10.9 |
| Onabotulinumtoxina | 81 | 9.9 | 9.9 |
| Botulinum Toxin Type A | 13 | 9.6 | 9.7 |
| Ciclesonide | 12 | 8.1 | 8.1 |
| Cenegermin-Bkbj | 10 | 7.6 | 7.6 |
| Cyclosporine | 88 | 7.5 | 7.5 |
| Tobramycin Solution | 9 | 6.9 | 6.9 |
| Tobramycin Sulfate | 9 | 6.7 | 6.7 |
| Lithium Carbonate | 12 | 6.5 | 6.5 |
| Panitumumab | 8 | 4.7 | 4.7 |
| Timolol | 6 | 4.6 | 4.6 |
| Aflibercept | 14 | 4.1 | 4.1 |
| Cannabidiol | 10 | 3.9 | 3.9 |
| Crisaborole | 4 | 3.8 | 3.8 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 4 | 3.5 | 3.5 |
| Iohexol | 3 | 3.3 | 3.3 |
| Cenobamate | 3 | 3.3 | 3.3 |
| Ranibizumab | 8 | 2.8 | 2.8 |
| Axitinib | 5 | 2.4 | 2.4 |
| Dupilumab | 117 | 2.3 | 2.3 |
| Ixazomib | 7 | 2.2 | 2.2 |
| Vigabatrin | 3 | 1.9 | 1.9 |
| Pirfenidone | 8 | 1.8 | 1.8 |
| Ranitidine Hydrochloride | 10 | 1.7 | 1.7 |